GlassScriptPhysician profile
Kevin Dean Steffen
NPI 1518259498
$2,600.53
in general payments reported to CMS, 2019-2025
15 companies · $237 in 2025
The $237 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,036 · 2020: $164 · 2021: $159 · 2022: $686 · 2023: $150 · 2024: $168 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $555.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,712.77 | 2019-2025 | 7 X 23mm Citrelock Implant, Flexband, Valor |
| Paragon 28, INC. | $355.95 | 2021-2022 | |
| Reapplix INC. | $93.23 | 2025 | 3c Patch Kit - Box |
| Organogenesis INC. | $84.77 | 2022-2024 | |
| Smith+Nephew, INC. | $59.16 | 2019-2024 | Pico 7 |
| Treace Medical Concepts, INC. | $49.01 | 2023-2024 | |
| Horizon Therapeutics Plc | $46.58 | 2022-2023 | Krystexxa |
| Boston Scientific Corporation | $41.58 | 2024 | |
| Kerecis Limited | $38.60 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Vertex Pharmaceuticals Incorporated | $29.56 | 2024 | |
| Polynovo North America LLC | $23.17 | 2025 | Novosorb Btm |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $21.07 | 2023 | Jublia |
| Axogen | $19.66 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Baudax Bio INC. | $13.28 | 2021 | |
| Depuy Synthes Sales INC. | $12.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Steffen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.